CD33 (Myeloid Cell Marker)

image not found

NABL Cap Accredited 
The Orange Healthcare CD33 (Myeloid Cell Marker) Test is a specialised diagnostic investigation used to detect CD33, a cell-surface protein primarily expressed on myeloid cells, including monocytes, granulocyte precursors, and certain immature blood cells. CD33 is an important immunophenotypic marker used to identify myeloid cell populations and support the diagnosis and classification of acute myeloid leukaemia (AML) and other myeloid disorders. The Orange Healthcare CD33 (Myeloid Cell Marker) Test helps characterise abnormal blood or bone marrow cells and may provide information relevant to targeted treatment decisions. CD33 expression alone cannot confirm malignancy. Results should be interpreted alongside other immunophenotypic markers, blood counts, bone marrow findings, and clinical investigations.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,750.00 Rs. 4,875.00

23% OFF

Sample Type: Blood

Fasting Not Required


Booking Procedure:
  1. Select your preferred Orange Health test or package on BookMyTest and complete your booking with your details.
  2. Pick a convenient time slot. A trained eMedic will be assigned and can reach you within 60 minutes of booking or at your scheduled time.
  3. At your selected time, a trained eMedic will visit your doorstep for safe and hygienic sample collection using a painless single-prick method. Samples are securely stored and transported to certified labs for processing.
  4. Doctor-verified reports are shared via WhatsApp, email, and the Orange Health app. You can also access them anytime from your registered account.

Frequently Asked Questions (FAQ's):

1. What is the Orange Healthcare CD33 (Myeloid Cell Marker) Test?
It is a specialised laboratory test used to detect CD33 protein expression on myeloid cells, helping identify and characterise normal and abnormal myeloid cell populations.

2. Why is the CD33 (Myeloid Cell Marker) Test performed?
The test is performed to support the diagnosis and classification of acute myeloid leukaemia, investigate abnormal myeloid cell populations, and assist in evaluating certain other haematological disorders.

3. What does a positive CD33 result indicate?
A positive result indicates CD33 expression in the examined cells. This may support myeloid lineage and is commonly observed in acute myeloid leukaemia. However, CD33 is also expressed on normal myeloid cells, so positivity alone does not establish a cancer diagnosis.

4. What does a negative CD33 result indicate?
A negative result means that CD33 expression was not detected in the examined cell population. Some myeloid malignancies may show weak or absent CD33 expression, so a negative result does not completely exclude acute myeloid leukaemia or other myeloid disorders.

5. Is fasting required for the Orange Healthcare CD33 (Myeloid Cell Marker) Test?
Fasting is generally not required. However, patients undergoing bone marrow aspiration, tissue biopsy, or procedures involving sedation should follow the preparation instructions provided by their healthcare team.

6. What sample is required for the CD33 (Myeloid Cell Marker) Test?
The required specimen depends on the clinical indication and testing method. Peripheral blood or bone marrow aspirate samples are commonly analysed using flow cytometry. Tissue biopsy specimens may also be examined using immunohistochemistry to assess CD33 expression.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab